Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Wiki/N-Phenethyl-Noroxymorphone

From altered.wiki
Revision as of 14:07, 11 May 2026 by Skali (talk | contribs) (Created page with "'''N-Phenethyl-Noroxymorphone''', also known by its acronym '''PHM''', is an extremely potent opioid of the morphinan class. Chemically it can be described as similar to opioid receptor antagonists such as Naloxone or Naltrexone, however, despite the chemical reassemblence, strongly activates the µ-Opioid receptors.<ref>A Comparative Analysis of N-Phenethylnoroxymorphone and Fentanyl Potency at the Mu-Opioid Receptor by BenchChem Technical Support Team. Released April 2...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

N-Phenethyl-Noroxymorphone, also known by its acronym PHM, is an extremely potent opioid of the morphinan class. Chemically it can be described as similar to opioid receptor antagonists such as Naloxone or Naltrexone, however, despite the chemical reassemblence, strongly activates the µ-Opioid receptors.[1] It has been encountered in research chemical shops in Germany and is as of May 2026 not federally scheduled there. PHM displays the same behavior as other opioid agonists, in that it leads to β-Arrestin 2 recruitment, so dependency and withdrawal if use of this substance is discontinued should be comparable to other more classical opioids such as fentanyl or morphine. The molecule is highly lipophilic due to the addition of a phenylethyl group, therefore it can penetrate the synaptic cleft stronger than a traditional opiate would. This effect is also visible with one of its sister compounds it is very closely related to, N-Phenethyl-Normorphine.[2][3] The compound, while being new to the research chemical market, has first been synthesized in the 1960s as a potent analgesic, but was never marketed.[4] Like many other drugs, its appearance can be described as a white powder without any notable odors or discolorations mentioned.

Pharmacology

PHM is highly selective for the mu-opioid receptor over the kappa-opioid receptor and presents roughly 2x the affinity and potency at the mu-opioid receptors that oxymorphone exhibits.

  1. A Comparative Analysis of N-Phenethylnoroxymorphone and Fentanyl Potency at the Mu-Opioid Receptor by BenchChem Technical Support Team. Released April 2026. Last fetched at 11 May 2026. Full text available at: https://pdf.benchchem.com/15621/A_Comparative_Analysis_of_N_Phenethylnoroxymorphone_and_Fentanyl_Potency_at_the_Mu_Opioid_Receptor.pdf
  2. Subramanian G, Paterlini MG, Portoghese PS, Ferguson DM (February 2000). "Molecular docking reveals a novel binding site model for fentanyl at the mu-opioid receptor". Journal of Medicinal Chemistry. 43 (3): 381–91. doi:10.1021/jm9903702. PMID 10669565.
  3. McFadyen I, Metzger T, Subramanian G, Poda G, Jorvig E, Ferguson DM (2002). Molecular modeling of opioid receptor-ligand complexes. Progress in Medicinal Chemistry. Vol. 40. pp. 107–35. doi:10.1016/S0079-6468(08)70083-3. ISBN 9780444510549. PMID 12516524.
  4. NPS Discovery - New Drug Monograph - N-Phenethyl Noroxymorphone. Center for Forensic Science Research & Education. 21 August 2024. Retrieved at 11 May 2026. Available at: https://www.drugsandalcohol.ie/41985/1/N-Phenethyl-Noroxymorphone-New-Drug-Monograph-NPS-Discovery.pdf